MSFinals-4896

A pharmaceutical company is presently conducting Phase 1-2 trials for Scarozyme, a new drug intended for the treatment of Meniere’s disease. The drug’s clearance is being evaluated, with the renal system being the primary means of clearance. What factors must be measured to determine the drug’s clearance at any given moment?